Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

For Staff

Communications, branding and engagement

Find out about editing your website profile, get presentation templates,  and more. Here.


Join us on Facebook and Twitter.


Our new intranet has been launched. You can find relevant information on finance, HR, our working culture, buildings, communications, and latest news and updates.  You can also go here for room bookings, Health & Safety information, etc.

Latest news

Kennedy Trust gift to help drive forward research into inflammatory and musculoskeletal diseases at Oxford

Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.

Tom Hosack awarded an MRC Fellowship

A DPhil candidate at NDORMS, Tom Hosack received the MRC Clinical Research Training Fellowship to further his research into tissue tropism in PD-1 therapy in immune-mediated inflammatory diseases.

New discovery furthers our understanding of how critical immune cells are controlled during an infection

A recent publication from Audrey Gérard’s lab looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.

Putting Multiple Myeloma onto a new course

The annual Oxford Myeloma Workshop brings together experts in myeloma research, clinical care, patient advocates and industry representatives, to help international efforts to improve patient lives affected by multiple myeloma. Multiple myeloma is the second most common among all blood cancers, is currently incurable and puts massive strains on patient quality of life with a significantly higher proportion (10 fold) share in health care costs.